1
|
Feron O: Pyruvate into lactate and back:
from the Warburg effect to symbiotic energy fuel exchange in cancer
cells. Radiother Oncol. 92:329–333. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Graeber GM, Clagett GP, Wolf RE, et al:
Alterations in serum creatine kinase and lactate dehydrogenase.
Association with abdominal aortic surgery, myocardial infarction
and bowel necrosis. Chest. 97:521–527. 1990. View Article : Google Scholar : PubMed/NCBI
|
3
|
Karlsson M, Wiberg-Itzel E, Chakkarapani
E, et al: Lactate dehydrogenase predicts hypoxic ischaemic
encephalopathy in newborn infants: a preliminary study. Acta
Paediatr. 99:1139–1144. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kato GJ, McGowan V, Machado RF, et al:
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric
oxide resistance, priapism, leg ulceration, pulmonary hypertension,
and death in patients with sickle cell disease. Blood.
107:2279–2285. 2006. View Article : Google Scholar : PubMed/NCBI
|
5
|
Eigentler TK, Figl A, Krex D, et al:
Dermatologic Cooperative Oncology Group and the National
Interdisciplinary Working Group on Melanoma: Number of metastases,
serum lactate dehydrogenase level, and type of treatment are
prognostic factors in patients with brain metastases of malignant
melanoma. Cancer. 117:1697–1703. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Escribano Subias P, Barberà Mir JA and
Suberviola V: Current diagnostic and prognostic assessment of
pulmonary hypertension. Rev Esp Cardiol. 63:583–96. 2010.PubMed/NCBI
|
7
|
Frost AE, Badesch DB, Barst RJ, et al: The
changing picture of pulmonary arterial hypertension patients in the
United States: how the REVEAL registry differs from historic and
non-US contemporary registries. Chest. 139:128–137. 2011.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Nagaya N, Nishikimi T, Uematsu M, et al:
Plasma brain natriuretic peptide as a prognostic indicator in
patients with primary pulmonary hypertension. Circulation.
102:865–870. 2000. View Article : Google Scholar : PubMed/NCBI
|
9
|
Humbert M, Sitbon O and Simonneau G:
Treatment of pulmonary arterial hypertension. N Engl J Med.
351:1425–1436. 2004. View Article : Google Scholar : PubMed/NCBI
|
10
|
Domingo E, Grignola JC, Aguilar R, et al:
Impairment of pulmonary vascular reserve and right ventricular
systolic reserve in pulmonary arterial hypertension. BMC Pulm Med.
14:692014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Batin P, Wickens M, McEntegart D, et al:
The importance of abnormalities of liver function tests in
predicting mortality in chronic heart failure. Eur Heart J.
16:1613–1618. 1995.PubMed/NCBI
|
12
|
Lau GT, Tan HC and Kritharides L: Type of
liver dysfunction in heart failure and its relation to the severity
of tricuspid regurgitation. Am J Cardiol. 90:1405–1409. 2002.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Poelzl G, Ess M, Mussner-Seeber C, et al:
Liver dysfunction in chronic heart failure: prevalence,
characteristics and prognostic significance. Eur J Clin Invest.
42:153–163. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
McGoon M, Gutterman D, Steen V, et al:
American College of Chest Physicians: Screening, early detection,
and diagnosis of pulmonary arterial hypertension: ACCP
evidence-based clinical practice guidelines. Chest. 126:(1 Suppl).
14S–34S. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Morrell NW, Yang X, Upton PD, et al:
Altered growth responses of pulmonary artery smooth muscle cells
from patients with primary pulmonary hypertension to transforming
growth factor-beta(1) and bone morphogenetic proteins. Circulation.
104:790–795. 2001. View Article : Google Scholar : PubMed/NCBI
|
16
|
Sakao S and Tatsumi K: Vascular remodeling
in pulmonary arterial hypertension: multiple cancer-like pathways
and possible treatment modalities. Int J Cardiol. 147:4–12. 2011.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Cottrill KA and Chan SY: Metabolic
dysfunction in pulmonary hypertension: the expanding relevance of
the Warburg effect. Eur J Clin Invest. 43:855–865. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Takeda Y, Takeda Y, Tomimoto S, et al:
Bilirubin as a prognostic marker in patients with pulmonary
arterial hypertension. BMC Pulm Med. 10:222010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Nagaya N, Nishikimi T, Uematsu M, et al:
Plasma brain natriuretic peptide as a prognostic indicator in
patients with primary pulmonary hypertension. Circulation.
102:865–870. 2000. View Article : Google Scholar : PubMed/NCBI
|